LENZ Therapeutics, Inc. (LENZ) › Weighted Average Diluted SharesLENZ Therapeutics, Inc. (LENZ) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2021-12-31: 28.92M2022-12-31: 54.87M2023-12-31: 1.96M2024-12-31: 21.28M2025-12-31: 28.81M28.81M2021-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3128.81M+35.4%2026-03-24From 2025-01-012024-12-3121.28M+986.3%2026-03-24From 2024-01-012023-12-311.96M-96.4%2025-03-19From 2023-01-012022-12-3154.87M+89.7%2024-02-27From 2022-01-012021-12-3128.92M—2023-03-20From 2021-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)